Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh · Delayed Price · Currency is BDT 52.90
-0.50 (-0.94%)
At close: Jan 22, 2026
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 5.68 billion as of January 23, 2026. Its market cap has increased by 5.59% in one year.
Market Cap
5.68B
Enterprise Value
9.70B
Revenue
9.52B
Ranking
n/a
PE Ratio
10.61
Stock Price
52.90
Market Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 5.68B, an increase of 100.38%. That is a compound annual growth rate of 23.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 5.68B | 1.93% |
| Dec 30, 2025 | 5.57B | 6.79% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
| Oct 18, 2022 | 2.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The ACME Laboratories | 15.62B |
| The IBN SINA Pharmaceutical Industry | 10.13B |
| Asiatic Laboratories | 6.56B |
| Orion Pharma | 6.51B |
| Techno Drugs | 4.17B |
| Ambee Pharmaceuticals | 1.70B |
| Pharma Aids | 1.57B |
| Silco Pharmaceuticals | 1.47B |